Evidence map›Paper›PMID 37965964›Full record

ArticleACS infectious diseases2023

Revised Model for the Type A Glycan Biosynthetic Pathway in

Bart Claushuis, Arnoud H de Ru, Sarah A Rotman, Peter A van Veelen, Lisa F Dawson, Brendan W Wren, Jeroen Corver, Wiep Klaas Smits, Paul J Hensbergen

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Bart ClaushuisCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.ORCID 0000-0002-7322-2187
Arnoud H de RuCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.
Sarah A RotmanCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.ORCID 0000-0002-7898-9408
Lisa F DawsonFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
Brendan W WrenFaculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.
Jeroen CorverDepartment of Medical Microbiology, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.ORCID 0000-0002-9262-5475
Wiep Klaas SmitsDepartment of Medical Microbiology, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.ORCID 0000-0002-7409-2847
Paul J HensbergenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden 2333 ZA, The Netherlands.ORCID 0000-0002-3193-5445
Leiden University Medical Center · NLUniversity of London · GB

Funding

Medical Research Council G1000214Medical Research Council MR/K000551/1Wellcome Trust 102979/Z/13/Z
6 · The paper itself

Abstract

The bacterial flagellum is involved in a variety of processes including motility, adherence, and immunomodulation. In the

Indexed as

Clostridioides difficileBiosynthetic PathwaysMass SpectrometryPolysaccharidesProteomicsPolysaccharidesbiosynthesisenzymeflagellaGlycosylationmass spectrometryproteomics

Identifiers

PMID37965964
PMCPMC10714395
OpenAlexW4388699807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.